Results 21 to 30 of about 122,153 (397)
BMC Medicine, 2022 Medical cannabinoids differ in their pharmacology and may have different treatment effects. We aimed to conduct a pharmacology-based systematic review (SR) and meta-analyses of medical cannabinoids for efficacy, retention and adverse events.
A. Bilbao, R. Spanagel
semanticscholar +1 more source
Shifts in medical cannabis use in Canada during the COVID-19 pandemic
Health Promotion and Chronic Disease Prevention in Canada, 2023 IntroductionThe COVID-19 pandemic has had widespread secondary negative health impacts including loss of material security and exacerbation of mental illness in at-risk populations.
Stephanie Lake +3 more
doaj +1 more source
Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic
Harm Reduction Journal, 2023 Background Prior to the COVID-19 pandemic, cannabis use social practices often involved sharing prepared cannabis (joints/blunts/cigarettes) and cannabis-related paraphernalia.
Ryan D. Assaf +5 more
doaj +1 more source
Cannabinoids as anticancer drugs: current status of preclinical research
British Journal of Cancer, 2022 Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the life quality of cancer patients.
B. Hinz, R. Ramer
semanticscholar +1 more source
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies.
Pain, 2021 This narrative review represents an output from the International Association for the Study of Pain's global task force on the use of cannabis, cannabinoids, and cannabis-based medicines (CBM) for pain management, informed by our companion systematic ...
D. Finn +5 more
semanticscholar +1 more source
Biomolecules, 2023 In this review article, we embark on a thorough exploration of cannabinoids, compounds that have garnered considerable attention for their potential therapeutic applications. Initially, this article delves into the fundamental background of cannabinoids,
Victor Voicu +9 more
doaj +1 more source
Cannabis and Cannabinoid Research, 2021 Introduction: Some cannabinoids have been identified as anti-inflammatory agents; however, their potential therapeutic or prophylactic applications remain controversial.
F. Henshaw +3 more
semanticscholar +1 more source
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Frontiers in Pharmacology, 2021 The medicinal use of Cannabis sativa L. can be traced back thousands of years to ancient China and Egypt. While marijuana has recently shown promise in managing chronic pain and nausea, scientific investigation of cannabis has been restricted due its ...
K. Walsh +2 more
semanticscholar +1 more source
Cannabinoids and Epilepsy [PDF]
Neurotherapeutics, 2015 Cannabis has been used for centuries to treat seizures. Recent anecdotal reports, accumulating animal model data, and mechanistic insights have raised interest in cannabis-based antiepileptic therapies. In this study, we review current understanding of the endocannabinoid system, characterize the pro- and anticonvulsive effects of cannabinoids [e.g ...
Evan C, Rosenberg +3 more
openaire +2 more sources
Cannabinoids and glaucoma [PDF]
British Journal of Ophthalmology, 2004 Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma.
Azuara-Blanco, A. +2 more
openaire +3 more sources